Skip to main content

Table 2 PCR changes during treatment

From: Sofosbuvir and daclatasvir are safe and effective in treatment of recurrent hepatitis C virus in Egyptian patients underwent living donor liver transplantation

Item

Frequency

Percentage

PCR before

 Mean ± SD

366057.5 ± 376220.9

 Min–max

698–2000000

PCR 1 month after starting treatment

 Positive

0

0

 Negative

40

100

PCR after the end of treatment

 Positive

0

0

 Negative

40

100

PCR 3 months after the end of treatment

 Positive

0

0

 Negative

40

100

PCR 6 months after the end of treatment

 Positive

0

0

 Negative

40

100

PCR 9 months after the end of treatment

 Positive

0

0

 Negative

40

100